Cennet Biopharma Cennet Biopharma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Prestwick3_000363

    Client Email Product

    Prestwick3_000363

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    28
    US DMFs Filed

    US DMFs Filed

    15
    CEP/COS Certifications

    CEP/COS Certifications

    8
    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    9
    Other Suppliers

    Other Suppliers

    15
    API REF. PRICE (USD / KG)
    5,162

    API Market Place

    8
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    30
    Europe

    Europe

    5
    Canada

    Canada

    7
    Australia

    Australia

    3
    South Africa

    South Africa

    7
    Uploaded Dossiers

    Uploaded Dossiers

    15
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    2,322.00

    Annual Reports

    286.00

    FDF Market Place

    7
    EXCIPIENTS
    209
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    34

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    45
    REF STANDARD

    EDQM

    2

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • CAPSULE;ORAL - 0.6MG
    • SOLUTION;ORAL - 0.6MG/5ML
    • TABLET;ORAL - 0.6MG
    Full View ScreenFull Screen View
    Annora Pharma's Generic Colchicine Receives Tentative ApprovalApprovals in the U.S
    Annora Pharma's Generic Colchicine Receives Tentative ApprovalApprovals in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215762

    FDA
    26 Mar 2024
    Share Share
    Scilex Announces Results from Research with Rheumatologists Reveal Interest in Gloperba
    Scilex Announces Results from Research with Rheumatologists Reveal Interest in Gloperba

    https://www.globenewswire.com//news-release/2023/12/19/2798587/0/en/Scilex-Holding-Company-Announces-Results-from-Market-Research-with-Rheumatologists-Reveal-a-High-Degree-of-Interest-in-Gloperba-as-a-Liquid-Colchicine-Formulation-Designed-for-Prec.html

    GLOBENEWSWIRE
    19 Dec 2023
    Share Share
    Takeda settles antitrust lawsuit over gout drug Colcrys
    Takeda settles antitrust lawsuit over gout drug Colcrys

    https://www.fiercepharma.com/pharma/takeda-settles-pay-delay-lawsuit-over-gout-drug-colcrys

    Angus Liu FIERCE PHARMA
    21 Sep 2023
    Share Share
    Micro Labs' Generic Colchicine Receives Approval in the U.S.
    Micro Labs' Generic Colchicine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212880

    FDA
    15 Aug 2023
    Share Share
    U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
    U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

    https://www.businesswire.com/news/home/20230620113838/en/U.S.-FDA-Approves-First-Anti-Inflammatory-Drug-for-Cardiovascular-Disease

    BUSINESSWIRE
    21 Jun 2023
    Share Share
    Enforcement Report - Week of March 22, 2023
    Enforcement Report - Week of March 22, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2023-25079.pdf

    FDA
    22 Mar 2023
    Share Share
    Annora's Generic Colchicine Receives Approval in the U.S.
    Annora's Generic Colchicine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215762

    FDA
    11 Jan 2023
    Share Share
    COVID-19 inpatients do not gain from aspirin and rivaroxaban
    COVID-19 inpatients do not gain from aspirin and rivaroxaban

    https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-inpatients-do-not-gain-from-aspirin-and-rivaroxaban-combined-or-colchicine-alone

    ESCARDIO
    29 Aug 2022
    Share Share
    COVID-19 patients in the community do not benefit from colchicine or aspirin
    COVID-19 patients in the community do not benefit from colchicine or aspirin

    https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-patients-in-the-community-do-not-benefit-from-colchicine-or-aspirin

    ESCARDIO
    29 Aug 2022
    Share Share
    Strides Pharma Gets USFDA Nod for Colchicine Tablets
    Strides Pharma Gets USFDA Nod for Colchicine Tablets

    https://medicaldialogues.in/news/industry/medical-devices/usfda-asks-philips-respironics-to-notify-patients-about-ventilator-recall-89826?infinitescroll=1

    MEDICAL DIALOGUES
    12 Mar 2022
    Share Share
    Strides Pharma's Generic Colchicine Receives Approval in the U.S.
    Strides Pharma's Generic Colchicine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209173

    FDA
    10 Mar 2022
    Share Share
    Aurobindo Pharma's Generic Colchicine Receives Approval in the U.S.
    Aurobindo Pharma's Generic Colchicine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215444

    FDA
    06 Jan 2022
    Share Share
    Pharmascience's MYINFLA, a new repurposed treatment now available in Canada
    Pharmascience's MYINFLA, a new repurposed treatment now available in Canada

    https://www.newswire.ca/news-releases/pharmascience-introduces-myinfla-tm-colchicine-0-5-mg-extended-release-tablets-a-new-repurposed-treatment-now-available-in-canada-to-reduce-the-risk-of-cardiovascular-disease-872812988.html

    NEWSWISE
    24 Sep 2021
    Share Share
    Health Canada approval of low-dose colchicine for CVD based on the COLCOT study
    Health Canada approval of low-dose colchicine for CVD based on the COLCOT study

    https://www.globenewswire.com/news-release/2021/08/27/2287639/0/en/Health-Canada-approval-of-low-dose-colchicine-for-cardiovascular-disease-based-on-the-COLCOT-study.html

    GLOBENEWSWIRE
    27 Aug 2021
    Share Share
    Controversy around colchicine percolates after study failure; AZ meeting
    Controversy around colchicine percolates after study failure; AZ meeting

    https://endpts.com/covid-19-roundup-controversy-around-colchicine-percolates-after-study-failure-astrazenecas-meeting-with-eu-was-constructive-but-didnt-solve-much/

    Amber Tong ENDPTS
    28 Jan 2021
    Share Share
    Colchicine reduces the risk of COVID-19-related complications
    Colchicine reduces the risk of COVID-19-related complications

    https://www.globenewswire.com/news-release/2021/01/23/2163109/0/en/Colchicine-reduces-the-risk-of-COVID-19-related-complications.html#:~:text=The%20study%20results%20have%20shown,COVID%2D19%20compared%20to%20placebo.&text=In%20these%20patients%20with%20a,%2C%20and%20deaths%20by%2044%25.

    GLOBENEWSWIRE
    25 Jan 2021
    Share Share
    Colchicine shows promise as a treatment for at-home COVID-19 patients
    Colchicine shows promise as a treatment for at-home COVID-19 patients

    https://www.globenewswire.com/news-release/2020/11/29/2135655/0/en/Colchicine-shows-promise-as-a-treatment-for-at-home-COVID-19-patients.html

    GLOBENEWSWIRE
    29 Nov 2020
    Share Share
    Pharmascience Inc. reiterates its support to the Montreal Heart Institute
    Pharmascience Inc. reiterates its support to the Montreal Heart Institute

    https://www.biospace.com/article/releases/pharmascience-inc-reiterates-its-support-to-the-montreal-heart-institute-s-colchicine-repurposing-research-studies-in-cardiovascular-medicine-and-covid-19/

    BIOSPACE
    31 Aug 2020
    Share Share
    Takeda Loses Appellate Bid to Bar Copycats of Colcrys Gout Drug
    Takeda Loses Appellate Bid to Bar Copycats of Colcrys Gout Drug

    https://news.bloomberglaw.com/ip-law/takeda-loses-appellate-bid-to-bar-copycats-of-colcrys-gout-drug

    IP LAW/TAKED
    31 Jul 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Gloperba 210942(Colchicine) Oral Solution 0.6 mg/5 mL
    FDA Confirms Paragraph IV Patent Challenge of Gloperba 210942(Colchicine) Oral Solution 0.6 mg/5 mL

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-gloperba-210942colchicine-oral-solution-06-mg5-ml-1590042988.pdf

    FDA
    21 May 2020
    Share Share
    New Trial Of Anti-Inflammatory Drug Colchicine; Will It Prevent Coronavirus
    New Trial Of Anti-Inflammatory Drug Colchicine; Will It Prevent Coronavirus

    https://www.techtimes.com/articles/249008/20200420/anti-covid-19-drug-new-trial-of-anti-inflammatory-drug-colchicine-can-this-preven-coronovirus-complications.htm

    Giuliano J. TECHTIMES
    22 Apr 2020
    Share Share
    Avion's new gout prophylaxis product, GLOPERBA®, liquid of colchicine (1,2)
    Avion's new gout prophylaxis product, GLOPERBA®, liquid of colchicine (1,2)

    https://www.prnewswire.com/news-releases/avion-pharmaceuticals-new-gout-prophylaxis-product-gloperba-is-the-first-and-only-liquid-form-of-colchicine-1-2-301012641.html

    PR NEWSWIRE
    27 Feb 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Colcrys 22352(Colchicine) For Tablets 0.3 mg
    FDA Confirms Paragraph IV Patent Challenge of Colcrys 22352(Colchicine) For Tablets 0.3 mg

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-colcrys-22352colchicine-for-tablets-03-mg-1566279179.pdf

    FDA
    21 Aug 2019
    Share Share
    ROMEG Therapeutics Receives FDA Approval of GLOPERBA® (colchicine)
    ROMEG Therapeutics Receives FDA Approval of GLOPERBA® (colchicine)

    https://www.businesswire.com/news/home/20190226005274/en/ROMEG-Therapeutics-Receives-FDA-Approval-GLOPERBA%C2%AE-colchicine/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J

    BUSINESSWIRE
    26 Feb 2019
    Share Share
    Par Pharm's Generic Colchicine Receives Approval in US
    Par Pharm's Generic Colchicine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208678

    FDA
    29 Nov 2018
    Share Share
    Recipharm Ltd. Fails EDQM Inspection
    Recipharm Ltd. Fails EDQM Inspection

    https://www.pharmacompass.com/pdf/news/recipharm-ltd-fails-edqm-inspection-1540034321.pdf

    EDQM
    20 Oct 2018
    Share Share
    Zydus Pharms USA's Generic Colchicine Receives Tentative Approval in US
    Zydus Pharms USA's Generic Colchicine Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211519

    FDA
    19 Oct 2018
    Share Share
    Colcrys® (colchicine, USP): Takeda Pharmaceuticals v. Alkem Laboratories
    Colcrys® (colchicine, USP): Takeda Pharmaceuticals v. Alkem Laboratories

    https://www.pharmacompass.com/pdf/news/colcrys-colchicine-usp-takeda-pharmaceuticals-v-alkem-laboratories-1517810817.pdf

    PATENT LITIGATION
    01 Feb 2018
    Share Share
    Colcrys® (Colchicine, Usp):Takeda Pharmaceuticals Usa V. Dr. Reddys Laboratories
    Colcrys® (Colchicine, Usp):Takeda Pharmaceuticals Usa V. Dr. Reddys Laboratories

    https://insight.rpxcorp.com/litigation_documents/12773093

    PATENT LITIGATION
    17 Jan 2018
    Share Share
    Mitigare® (Colchicine): West-Ward Pharma Corp v. Granules Pharmaceuticals, Usa
    Mitigare® (Colchicine): West-Ward Pharma Corp v. Granules Pharmaceuticals, Usa

    https://www.pharmacompass.com/pdf/news/mitigare-colchicine-west-ward-pharma-corp-v-granules-pharmaceuticals-usa-1517214884.pdf

    PATENT LITIGATION
    12 Jan 2018
    Share Share
    Granules, Hetero in patent battle with Takeda Pharma
    Granules, Hetero in patent battle with Takeda Pharma

    http://www.thehindubusinessline.com/companies/article9818570.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication

    M SOMASEKHAR THE HINDU BUSINESS LINE
    15 Aug 2017
    Share Share
    Briefing in Appeal Over Colchicine 505(b)(2) Approval Wraps Up
    Briefing in Appeal Over Colchicine 505(b)(2) Approval Wraps Up

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2016/01/briefing-in-appeal-over-colchicine-505b2-approval-wraps-up-oral-argument-and-a-decision-are-patientl.html

    Kurt R. Karst FDA LAWBLOG
    11 Jan 2016
    Share Share
    Hikma shares take a knock after gout drug fails to take off
    Hikma shares take a knock after gout drug fails to take off

    http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11969525/Hikma-lowers-guidance-after-gout-drug-fails-to-take-off.html

    Julia Bradshaw THE TELEGRAPH
    03 Nov 2015
    Share Share
    How Marketing Exclusivity Led to Higher Drug Costs and Questionable Benefits
    How Marketing Exclusivity Led to Higher Drug Costs and Questionable Benefits

    http://blogs.wsj.com/pharmalot/2015/05/05/how-marketing-exclusivity-led-to-higher-drug-costs-and-questionable-benefits/

    Ed Silverman PHARMALOT
    06 May 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews
    Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews

    http://www.fiercepharmaasia.com/story/japan-mhlw-panel-names-11-unapprovedoff-label-drugs-fast-track-reviews/2015-04-27

    Ej Lane FIERCE PHARMA ASIA
    28 Apr 2015
    Share Share
    Otsuka scrambles to persuade judge to block Abilify copycats
    Otsuka scrambles to persuade judge to block Abilify copycats

    http://www.fiercepharma.com/story/otsuka-scrambles-persuade-judge-block-abilify-copycats/2015-04-16

    Tracy Staton FIERCE PHARMA
    17 Apr 2015
    Share Share
    Study Says No Good Has Come From FDA's Action On Gout Drug Colchicine
    Study Says No Good Has Come From FDA's Action On Gout Drug Colchicine

    http://www.fiercepharma.com/story/study-says-no-good-has-come-fdas-action-gout-drug-colchicine/2015-04-10

    Eric Palmer FIERCE PHARMA
    13 Apr 2015
    Share Share
    CymaBay Drug Not Better Than Current Care In Reducing Uric Acid
    CymaBay Drug Not Better Than Current Care In Reducing Uric Acid

    http://www.reuters.com/article/2015/02/24/us-cymabay-urgent-idUSKBN0LS11Y20150224

    Rosmi Shaji And Vidya L Nathan REUTERS
    25 Feb 2015
    Share Share
    Par Pharm's Generic Colchicine (Colchicine 0.6 Mg) Tentatively Approved in USA for Gout
    Par Pharm's Generic Colchicine (Colchicine 0.6 Mg) Tentatively Approved in USA for Gout

    https://www.pharmacompass.com/pdf/news/n3.pdf

    FDA
    12 Feb 2015
    Share Share
    Mylan Said to be Eyeing a $7B-Plus Bid for Rising Star Hikma
    Mylan Said to be Eyeing a $7B-Plus Bid for Rising Star Hikma

    http://www.fiercepharma.com/story/mylan-said-be-eyeing-7b-plus-bid-rising-star-hikma/2015-01-28

    Tracy Staton FIERCE PHARMA
    29 Jan 2015
    Share Share
    District Court Tackles Sticky 505(b)(2) Application Issues in an Extensive Memorandum Opinion Involving Colchicine
    District Court Tackles Sticky 505(b)(2) Application Issues in an Extensive Memorandum Opinion Involving Colchicine

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-tackles-sticky-505b2-application-issues-in-an-extensive-memorandum-opinion-involving-.html

    Kurt R. Karst FDA LAW BLOG
    21 Jan 2015
    Share Share
    Takeda Plans Appeal in Patent Litigation for Colchicine Signs Pact for Authorized Generic
    Takeda Plans Appeal in Patent Litigation for Colchicine Signs Pact for Authorized Generic

    http://connect.dcat.org/blogs/pharma-news/2015/01/15/takeda-plans-appeal-in-patent-litigation#.VLijKtKUde8

    DCAT CONNECT
    16 Jan 2015
    Share Share
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-sides-with-fda-505b2-applicant-in-challenge-to-colchicine-capsules-approval-an-appeal.html

    Kurt R. Karst FDA LAW BLOG
    12 Jan 2015
    Share Share
    Heartburn Drugs Have Serious Side Effects
    Heartburn Drugs Have Serious Side Effects

    http://seattletimes.com/html/health/2025372239_pharmacy11xml.html

    Joe And Teresa Graedon THE SEATTLE TIMES
    12 Jan 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Alchem Colchicine

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Sarv BioLabs Colchicine

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search